Related Experiment Video

Updated: Aug 29, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

[Left ventricular hypertrophy in hypertension. Part II. Prognostic value of left ventricular hypertrophy]

D V Preobrazhenskiĭ1, B A Sidorenko, M N Alekhin

  • 1Presidential Medical Center of Russia; ul. Marshala Timoschenco 15, 121356 Moscow, Russia.

Kardiologiia
|December 13, 2003
PubMed

Insights

Left ventricular hypertrophy, detected by ECG or echocardiography, significantly increases cardiovascular risk. This condition, along with myocardial mass, is a key prognostic factor for heart disease.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Clinical Electrophysiology

Context:

  • Left ventricular hypertrophy (LVH) is a common cardiac condition.
  • Accurate prognostic assessment of LVH is crucial for patient management.
  • Prospective studies are vital for understanding the long-term implications of cardiac structural changes.

Purpose:

  • To review the prognostic value of left ventricular hypertrophy (LVH) using electrocardiography (ECG) and echocardiography.
  • To evaluate the association between LVH and cardiovascular complications.
  • To determine the independent prognostic significance of left ventricular myocardial mass.

Summary:

  • LVH, identified by ECG voltage criteria or ST-T wave changes, is linked to a higher risk of cardiovascular complications.
  • Left ventricular myocardial mass is an independent prognostic factor.
  • The prognostic impact of LVH varies based on diagnostic criteria, patient demographics (age, sex, race), and comorbidities like coronary heart disease.

Impact:

  • Findings highlight the importance of detecting LVH for risk stratification.
  • Understanding LVH's prognostic significance aids in tailoring preventative strategies.
  • This review provides insights into the long-term cardiovascular risks associated with LVH.

More Related Videos

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...